PortfoliosLab logoPortfoliosLab logo
REGN vs. SRLN
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

REGN vs. SRLN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Regeneron Pharmaceuticals, Inc. (REGN) and SPDR Blackstone Senior Loan ETF (SRLN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, REGN achieves a -18.32% return, which is significantly lower than SRLN's 0.73% return. Both investments have delivered pretty close results over the past 10 years, with REGN having a 4.61% annualized return and SRLN not far behind at 4.52%.


REGN

1D
1.58%
1M
-10.34%
YTD
-18.32%
6M
-12.78%
1Y
30.36%
3Y*
-5.46%
5Y*
4.37%
10Y*
4.61%

SRLN

1D
0.05%
1M
0.33%
YTD
0.73%
6M
1.31%
1Y
5.62%
3Y*
7.83%
5Y*
4.63%
10Y*
4.52%
*Multi-year figures are annualized to reflect compound growth (CAGR)

REGN vs. SRLN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
REGN
Regeneron Pharmaceuticals, Inc.
-18.32%8.96%-18.90%21.73%14.25%30.72%28.66%0.53%-0.65%2.42%
SRLN
SPDR Blackstone Senior Loan ETF
0.73%6.77%8.43%11.62%-5.30%4.49%3.13%10.03%-0.66%3.39%

Correlation

The correlation between REGN and SRLN is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (10Y)
Calculated over the trailing 10-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Apr 5, 2013

0.17

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

REGN vs. SRLN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

REGN
REGN Risk / Return Rank: 6767
Overall Rank
REGN Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
REGN Sortino Ratio Rank: 6666
Sortino Ratio Rank
REGN Omega Ratio Rank: 6464
Omega Ratio Rank
REGN Calmar Ratio Rank: 6565
Calmar Ratio Rank
REGN Martin Ratio Rank: 7272
Martin Ratio Rank

SRLN
SRLN Risk / Return Rank: 5555
Overall Rank
SRLN Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
SRLN Sortino Ratio Rank: 6262
Sortino Ratio Rank
SRLN Omega Ratio Rank: 7676
Omega Ratio Rank
SRLN Calmar Ratio Rank: 3636
Calmar Ratio Rank
SRLN Martin Ratio Rank: 4141
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

REGN vs. SRLN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and SPDR Blackstone Senior Loan ETF (SRLN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


REGNSRLNDifference
Sharpe ratioReturn per unit of total volatility

-1.03

Sortino ratioReturn per unit of downside risk

-1.37

Omega ratioGain probability vs. loss probability

1.18

1.45

-0.26

Calmar ratioReturn relative to maximum drawdown

1.18

1.73

-0.55

Martin ratioReturn relative to average drawdown

4.09

6.41

-2.32

REGN vs. SRLN - Sharpe Ratio Comparison

The current REGN Sharpe Ratio is 0.93, which is lower than the SRLN Sharpe Ratio of 1.95. The chart below compares the historical Sharpe Ratios of REGN and SRLN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


REGNSRLNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.93

1.95

-1.03

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.14

1.19

-1.05

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.14

0.75

-0.60

Sharpe Ratio (All Time)

Calculated using the full available price history

0.16

0.70

-0.54

Drawdowns

REGN vs. SRLN - Drawdown Comparison

The maximum REGN drawdown since its inception was -91.81%, which is greater than SRLN's maximum drawdown of -22.29%. Use the drawdown chart below to compare losses from any high point for REGN and SRLN.


Loading charts...

Drawdown Indicators


REGNSRLNDifference

Max Drawdown

Largest peak-to-trough decline

-91.81%

-22.29%

-69.52%

Max Drawdown (1Y)

Largest decline over 1 year

-25.85%

-3.26%

-22.59%

Max Drawdown (3Y)

Largest decline over 3 years

-59.69%

-4.26%

-55.43%

Max Drawdown (5Y)

Largest decline over 5 years

-59.69%

-7.93%

-51.76%

Max Drawdown (10Y)

Largest decline over 10 years

-59.69%

-22.29%

-37.40%

Current Drawdown

Current decline from peak

-47.25%

-0.07%

-47.18%

Average Drawdown

Average peak-to-trough decline

-42.39%

-1.10%

-41.29%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.45%

0.88%

+6.57%

Volatility

REGN vs. SRLN - Volatility Comparison

Regeneron Pharmaceuticals, Inc. (REGN) has a higher volatility of 12.54% compared to SPDR Blackstone Senior Loan ETF (SRLN) at 0.44%. This indicates that REGN's price experiences larger fluctuations and is considered to be riskier than SRLN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


REGNSRLNDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.54%

0.44%

+12.10%

Volatility (6M)

Calculated over the trailing 6-month period

22.39%

2.64%

+19.75%

Volatility (1Y)

Calculated over the trailing 1-year period

32.85%

2.89%

+29.96%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

30.77%

3.91%

+26.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.16%

6.06%

+26.10%

Dividends

REGN vs. SRLN - Dividend Comparison

REGN's dividend yield for the trailing twelve months is around 0.58%, less than SRLN's 7.49% yield.


PositionTTM20252024202320222021202020192018201720162015
REGN
Regeneron Pharmaceuticals, Inc.
0.58%0.46%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SRLN
SPDR Blackstone Senior Loan ETF
7.49%7.67%8.58%8.44%5.72%4.45%4.91%5.39%4.98%4.01%3.94%4.43%

Frequently Asked Questions


REGN and SRLN have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

REGN has higher volatility (12.54%) compared to SRLN (0.44%). In terms of maximum drawdown, REGN dropped -91.81% vs SRLN's -22.29%.

SRLN currently has the higher Sharpe Ratio (1.95 vs 0.93), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for REGN and SRLN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer